Clinical Trials Logo

Clinical Trial Summary

High level of security during blood transfusion has been achieved by donor selection and pathogen detection using serology or direct identification. Nevertheless, blood banking becomes hazardous during epidemic outbreaks or facing new pathogens. Amotosalen, a psoralen, targets nucleic acids and destroys them after ultraviolet exposure, resulting in inactivation of pathogens. Treatment inoccuity and efficacy have been demonstrated but preservation of platelet functions after treatment is still debated. Previous studies focused on hematological patients. There is no evidence for an increased requirement of transfused platelets to achieve platelet count target. Studies in heart surgery are lacking. The investigators perform a multicenter, retrospective, "before/after", controlled study in minor patients requiring heart surgery with cardiopulmonary bypass. One center (Strasbourg) uses Amotosalen-treated platelet concentrates since 2006 (control arm). This treatment becomes available in Bordeaux in October 2017 (intervention arm). There is two periods of inclusion: one "before" (January 2016 to June 2017) and one "after" (January 2018 to June 2019).

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05128084
Study type Observational
Source University Hospital, Strasbourg, France
Contact Xavier DELABRANCHE, MD
Phone 33 3 69 55 09 36
Email [email protected]
Status Recruiting
Start date October 1, 2020
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04158024 - Erector Spinae Plane Block in Congenital Heart Disease Patients N/A
Not yet recruiting NCT04040452 - Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery Phase 4
Recruiting NCT04315610 - Personalized Mobile App for Parents of Infants With Cardiac Disease N/A
Recruiting NCT03229538 - STeroids to REduce Systemic Inflammation After Infant Heart Surgery Phase 3
Recruiting NCT04604418 - Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
Recruiting NCT04666857 - Family Centred Early Intervention of Infants With Congenital Heart Disease N/A
Terminated NCT03136900 - Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of With Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation,After Surgery for Congenital Heart Disease, in Infants. N/A
Recruiting NCT04295239 - Non-invasive Monitoring of Cerebral Self-regulation in Perioperative Neonatal Cardiac Surgery N/A
Completed NCT04018079 - Left Ventricular Dysfunction Post-surgical Patent Ductus Arteriosus Ligation in Children: Predictor Factors Analysis
Not yet recruiting NCT04307030 - Study on AI Recognition System Of Heart Sound In Congenital Heart Disease Screening
Recruiting NCT04217421 - Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass Phase 3
Completed NCT03882450 - Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery N/A
Completed NCT04966312 - Preoperative Educational Videos Reduce Maternal Anxiety Whose Children Received Congenital Heart Disease Surgery N/A
Completed NCT05022836 - Four-limb Blood Pressures in Infants With High Risk of Congenital Malformation of Aorta
Completed NCT03144011 - Acute Kidney Injury in Children After Cardiopulmonary Bypass
Completed NCT04597021 - Wireless US-guided CVC Placement in Infants